Mexican Pharma Waits On Domestic Debut

Mexican Pharma Waits On Domestic Debut

Mexico Bonds

Genomma Lab has decided wait on pricing of its domestic market bond debut, due to market volatility, according to people following the sale. The Mexican pharmaceutical and hygiene products company was targeting Thursday for the pricing of up to MXP2.

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial